In the abstracted data, several variables differed significantly between T1D and T2D patients, including BMI, gender, C-peptide, anti-GAD autoantibodies, current use of oral diabetes medications, hyperpigmentation, and family history for T2D (data not shown). This evidence concerns the gene GAD1 and type 2 diabetes mellitus.